Bibliography
- DAHLOF B, SEVER PS, POULTER NR et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA); a multicenter randomised controlled trial. Lancet (2005) 366:895-906.
- POULTER NR, WEDEL H, DAHLOP B et al.: Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet (2005) 366:907-913.
- THE ALLHAT OFFICERS AND COORDINATORS FOR THE ALLHAT COLLABORATIVE RESEARCH GROUP: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA (2002) 288:2981-2997.
- CARLBERG B, SAMUELSSON O, LINDHOLM LH: Atenolol in hypertension: is it a wise choice? Lancet (2004) 364:1684-1689.
- BLOOD PRESSURE LOWERING TREATMENT TRIALISTS’ COLLABORATION: Effect of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet (2003) 362:1527-1535.
- MASON RP, WALTER MR, TRUMBORE MW, OLMSTEAD EG Jr, MASON PE: Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J. Mol. Cell. Cardiol. (1999) 31:275-281.
- ASANUMA H, MINAMINO T, SANADA S et al.: A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts. J. Mol. Cell. Cardiol. (2005) 39:605-614.
- OLSEN MH, FOSSUM E, HOIGGEN A et al.: Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy. J. Hypertens. (2005) 23:891-898.
- BERTRAND ME: Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr. Med. Res. Opin. (2004) 20:1559-1569.
- WRIGHT JT, DUNN JK, CUTLER JA et al.: Outcome in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA (2005) 293:1595-1607.
- RUILOPE LM, MALACCO E, KHDER Y et al.: Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Clin Ther (2005) 27:578-587.
- WEIR MR, FERDINAND KC, FLACK JM et al.: A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives. Hypertension (2005) 46:508-513.
- NEUTEL JM, SMITH DH, WEBER MA et al.: Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study. J. Clin. Hypertens. (2005) 7:641-646.